Investor Alert: Join the Class Action Against LifeMD, Inc. for Securities Fraud

Investor Alert: Class Action Lawsuit Against LifeMD, Inc.

Pomerantz LLP has initiated a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) following significant price drops in the company's stock due to alleged fraudulent activities. Investors who believe they suffered losses on their investments during the specified class period are encouraged to take action before the upcoming deadlines.

On August 5, 2025, LifeMD announced its second-quarter results and revealed setbacks impacting its Rex MD business, which led the company to adjust its revenue projections for the year. Chief Financial Officer Marc Benathen indicated that while some challenges had been addressed, they would still affect the financial outlook. As a result, the company’s stock plummeted 44.85%, closing at $6.53 on August 6, 2025. This drastic decline has raised suspicions about the integrity of LifeMD's operations and financial reporting.

If you are an investor who purchased LifeMD securities during this time, you could be eligible to join the class-action suit. The deadline to request to be appointed as a Lead Plaintiff is October 27, 2025. Interested parties should reach out to Pomerantz LLP for more details on how to participate in this legal action. The firm advises those who inquire to include their contact information and specifics about their purchases of LifeMD shares.

Founded by Abraham L. Pomerantz, a pioneer in securities class actions, the firm has a long-standing history of advocating for victims of corporate misconduct, recovering significant damages on behalf of affected investors. With over 85 years in the field, Pomerantz is recognized as one of the foremost firms in this area, exemplifying the fight against securities fraud.

For those looking to learn more about this class-action lawsuit or to obtain a copy of the complaint, please visit www.pomerantzlaw.com. Additionally, investors can reach Danielle Peyton at 646-581-9980 or through email at [email protected].

In these uncertain times, protecting your investments is crucial. This alert serves as a reminder for investors to stay informed and take necessary actions to safeguard their rights. The class action is not just a means of seeking restitution but an opportunity for investors to make a statement against corporate negligence and uphold ethical standards in business practices.

In summary, the class action against LifeMD represents an essential step for investors who have experienced losses due to potential securities violations. As details unfold, affected parties must act promptly to ensure their voice is heard in the legal proceedings. Pomerantz LLP remains committed to defending the rights of investors and achieving justice in this significant case.